Takeda secures AI platform from biotech startup Iambic for drug discovery

Deal worth up to $1.7 billion targets oncology and inflammation using automated protein-ligand prediction models

13-Feb-2026 - San Diego-based biotechnology startupIambic announced a multi-year technology and discovery collaboration agreement with Takeda that will use Iambic’s industry leading AI drug discovery models to advance a select set of high-priority small molecule programs, initially in Takeda’s Oncology and ...